Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review

被引:250
作者
McDonald, Marguerite [1 ]
Patel, Dipen A. [2 ]
Keith, Michael S. [3 ]
Snedecor, Sonya J. [2 ]
机构
[1] NYU, Langone Med Ctr, New York, NY USA
[2] Pharmerit Int, Bethesda, MD USA
[3] Shire, Wayne, PA USA
关键词
Burden of disease; cost; dry eye disease; quality of life; systematic literature review; QUALITY-OF-LIFE; MEIBOMIAN GLAND DYSFUNCTION; SJOGRENS-SYNDROME; UTILITY-ASSESSMENT; FUNCTIONAL STATUS; PREVALENCE; SYMPTOMS; IMPACT; QUESTIONNAIRE; POPULATION;
D O I
10.1016/j.jtos.2015.11.002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Dry eye disease (DED) is a chronic and progressive multifactorial disorder of the tears and ocular surface, which results in symptoms of discomfort and visual disturbance. The aim of this systematic literature review was to evaluate the burden of DED and its components from an economic and health-related quality of life (HRQoL) perspective, and to compare the evidence across France, Germany, Italy, Spain, UK, USA, Japan, and China. PubMed, Embase, and six other resources were searched for literature published from January 1998 to July 2013. Of 76 titles/abstracts reviewed on the economic burden of DED and 263 on the HRQoL burden, 12 and 20 articles, respectively, were included in the review. The available literature suggests that DED has a substantial economic burden, with indirect costs making up the largest proportion of the overall cost due to a substantial loss of work productivity. In addition, DED has a substantial negative impact on physical, and potentially psychological, function and HRQoL across the countries examined. A number of studies also indicated that HRQoL burden increases with the severity of disease. Additional data are needed, particularly in Asia, in order to gain a better understanding of the burden of DED and help inform future health care resource utilization.
引用
收藏
页码:144 / 167
页数:24
相关论文
共 68 条
[1]   Development and validation of the Impact of Dry Eye on Everyday Life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients [J].
Abetz, Linda ;
Rajagopalan, Krithika ;
Mertzanis, Polyxane ;
Begley, Carolyn ;
Barnes, Rod ;
Chalmers, Robin .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2011, 9
[2]   The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity [J].
Begley, CG ;
Chalmers, RL ;
Abetz, L ;
Venkataraman, K ;
Mertzanis, P ;
Caffery, BA ;
Snyder, C ;
Edrington, T ;
Nelson, D ;
Simpson, T .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (11) :4753-4761
[3]  
Belenguer R, 2005, CLIN EXP RHEUMATOL, V23, P351
[4]   Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool [J].
Bowman, SJ ;
Booth, DA ;
Platts, RG .
RHEUMATOLOGY, 2004, 43 (06) :758-764
[5]  
BROWN GC, 2009, EVIDENCE BASED OPHTH, V10, P166
[6]   Value-Based Medicine, Comparative Effectiveness, and Cost-effectiveness Analysis of Topical Cyclosporine for the Treatment of Dry Eye Syndrome [J].
Brown, Melissa M. ;
Brown, Gary C. ;
Brown, Heidi C. ;
Peet, Jonathan ;
Roth, Zachary .
ARCHIVES OF OPHTHALMOLOGY, 2009, 127 (02) :146-152
[7]   Utility assessment to measure the impact of dry eye disease [J].
Buchholz, Patricia ;
Steeds, Carolyn S. ;
Stern, Lee S. ;
Wiederkehr, Daniel P. ;
Doyle, John J. ;
Katz, Laura M. ;
Figueiredo, Francisco C. .
OCULAR SURFACE, 2006, 4 (03) :155-161
[8]   The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists [J].
Clegg, John P. ;
Guest, Julian F. ;
Lehman, Almut ;
Smith, Andrew F. .
OPHTHALMIC EPIDEMIOLOGY, 2006, 13 (04) :263-274
[9]  
Cross Warren D, 2002, Manag Care Interface, V15, P44
[10]  
Dalzell Michael D, 2003, Manag Care, V12, P9